DEFLUX INJECTABLE GEL
FDA premarket approval P000029/S001 · decided 2002-09-23
Approval details
- PMA number
- P000029
- Supplement
- S001
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- DEFLUX INJECTABLE GEL
- Generic name
- AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
- Applicant
- Palette Life Sciences
- Date received
- 2002-09-10
- Decision date
- 2002-09-23
- Days to decision
- 13 days
- Decision code
- OK30
- Product code
- LNM
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Santa Barbara, CA
- Statement
- CHANGE IN THE SITE FOR BACTERIAL ENDOTOXIN TESTING OF CERTAIN COMPONENTS USED IN DEFLUX INJECTABLE GEL, INTENDED FOR TREATMENT OF VESICOURETERAL REFLUX IN CHILDREN.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Barrigel Injectable Gel (K220641) | Palette Life Sciences | 2022-05-26 |